staurosporine aglycone has been researched along with Akinetic-Rigid Variant of Huntington Disease in 1 studies
staurosporine aglycone: metabolite from culture broth of Nocardiopsis sp.; a neurotrophin antag; inhibits BDNF TrkB receptor
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Apostol, BL | 1 |
| Simmons, DA | 1 |
| Zuccato, C | 1 |
| Illes, K | 1 |
| Pallos, J | 1 |
| Casale, M | 1 |
| Conforti, P | 1 |
| Ramos, C | 1 |
| Roarke, M | 1 |
| Kathuria, S | 1 |
| Cattaneo, E | 1 |
| Marsh, JL | 1 |
| Thompson, LM | 1 |
1 other study available for staurosporine aglycone and Akinetic-Rigid Variant of Huntington Disease
| Article | Year |
|---|---|
CEP-1347 reduces mutant huntingtin-associated neurotoxicity and restores BDNF levels in R6/2 mice.
Topics: Animals; Animals, Genetically Modified; Brain-Derived Neurotrophic Factor; Carbazoles; Cell Line; Di | 2008 |